UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004313 |
|---|---|
| Receipt number | R000005049 |
| Scientific Title | A phase 1 study of 5-FU and sorafenib combination therapy in patients with hepatocellular carcinoma. Non-blind dosage gradual increase study |
| Date of disclosure of the study information | 2010/10/03 |
| Last modified on | 2020/07/13 11:46:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/10/02 20:45:53 | ||
| 2 | Update | 2012/04/03 10:30:59 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2020/06/10 10:02:16 | UMIN ID1 |
|
| 4 | Update | 2020/07/13 11:44:08 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2020/07/13 11:46:44 | Number of participants that the trial has enrolled |
